Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Differentiating lung cancer and infection based on measurements of extracellular pH with acidoCEST MRI.

Lindeman LR, Jones KM, High RA, Howison CM, Shubitz LF, Pagel MD.

Sci Rep. 2019 Sep 10;9(1):13002. doi: 10.1038/s41598-019-49514-1.

2.

Clinical features of cats diagnosed with coccidioidomycosis in Arizona, 2004-2018.

Arbona N, Butkiewicz CD, Keyes M, Shubitz LF.

J Feline Med Surg. 2019 Feb 20:1098612X19829910. doi: 10.1177/1098612X19829910. [Epub ahead of print]

PMID:
30784342
3.

Selected Clinical Features of Coccidioidomycosis in Dogs.

Davidson AP, Shubitz LF, Alcott CJ, Sykes JE.

Med Mycol. 2019 Feb 1;57(Supplement_1):S67-S75. doi: 10.1093/mmy/myy113. Review.

PMID:
30690600
4.

Coccidioidomycosis in alpacas in the southwestern United States.

Butkiewicz CD, Shubitz LF.

Transbound Emerg Dis. 2019 Mar;66(2):807-812. doi: 10.1111/tbed.13088. Epub 2018 Dec 14.

PMID:
30506909
5.

Viable spores of Coccidioides posadasii Δcps1 are required for vaccination and provide long lasting immunity.

Shubitz LF, Powell DA, Trinh HT, Lewis ML, Orbach MJ, Frelinger JA, Galgiani JN.

Vaccine. 2018 May 31;36(23):3375-3380. doi: 10.1016/j.vaccine.2018.04.026. Epub 2018 Apr 30.

6.

The Novel Fungal Cyp51 Inhibitor VT-1598 Is Efficacious in Experimental Models of Central Nervous System Coccidioidomycosis Caused by Coccidioides posadasii and Coccidioides immitis.

Wiederhold NP, Shubitz LF, Najvar LK, Jaramillo R, Olivo M, Catano G, Trinh HT, Yates CM, Schotzinger RJ, Garvey EP, Patterson TF.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e02258-17. doi: 10.1128/AAC.02258-17. Print 2018 Apr.

7.

Development of an enzyme immunoassay for detection of antibodies against Coccidioides in dogs and other mammalian species.

Chow NA, Lindsley MD, McCotter OZ, Kangiser D, Wohrle RD, Clifford WR, Yaglom HD, Adams LE, Komatsu K, Durkin MM, Baker RJ, Shubitz LF, Derado G, Chiller TM, Litvintseva AP.

PLoS One. 2017 Apr 5;12(4):e0175081. doi: 10.1371/journal.pone.0175081. eCollection 2017.

8.

Efficacy of the Investigational Antifungal VT-1161 in Treating Naturally Occurring Coccidioidomycosis in Dogs.

Shubitz LF, Roy ME, Trinh HT, Hoekstra WJ, Schotzinger RJ, Garvey EP.

Antimicrob Agents Chemother. 2017 Apr 24;61(5). pii: e00111-17. doi: 10.1128/AAC.00111-17. Print 2017 May.

9.

A Coccidioides posadasii CPS1 Deletion Mutant Is Avirulent and Protects Mice from Lethal Infection.

Narra HP, Shubitz LF, Mandel MA, Trinh HT, Griffin K, Buntzman AS, Frelinger JA, Galgiani JN, Orbach MJ.

Infect Immun. 2016 Sep 19;84(10):3007-16. doi: 10.1128/IAI.00633-16. Print 2016 Oct.

10.

Evaluation of VT-1161 for Treatment of Coccidioidomycosis in Murine Infection Models.

Shubitz LF, Trinh HT, Galgiani JN, Lewis ML, Fothergill AW, Wiederhold NP, Barker BM, Lewis ER, Doyle AL, Hoekstra WJ, Schotzinger RJ, Garvey EP.

Antimicrob Agents Chemother. 2015 Dec;59(12):7249-54. doi: 10.1128/AAC.00593-15. Epub 2015 Sep 14.

11.

Modeling nikkomycin Z dosing and pharmacology in murine pulmonary coccidioidomycosis preparatory to phase 2 clinical trials.

Shubitz LF, Trinh HT, Perrill RH, Thompson CM, Hanan NJ, Galgiani JN, Nix DE.

J Infect Dis. 2014 Jun 15;209(12):1949-54. doi: 10.1093/infdis/jiu029. Epub 2014 Jan 12.

12.

Efficacy of Nikkomycin Z for respiratory coccidioidomycosis in naturally infected dogs.

Shubitz LF, Roy ME, Nix DE, Galgiani JN.

Med Mycol. 2013 Oct;51(7):747-54. doi: 10.3109/13693786.2013.770610. Epub 2013 Mar 14.

PMID:
23488972
13.

Mouse models for the study of fungal pneumonia: a collection of detailed experimental protocols for the study of Coccidioides, Cryptococcus, Fusarium, Histoplasma and combined infection due to Aspergillus-Rhizopus.

Muhammed M, Feldmesser M, Shubitz LF, Lionakis MS, Sil A, Wang Y, Glavis-Bloom J, Lewis RE, Galgiani JN, Casadevall A, Kontoyiannis DP, Mylonakis E.

Virulence. 2012 May 1;3(3):329-38. doi: 10.4161/viru.20142. Epub 2012 May 1.

14.

T-lymphocyte predominance in lesions of canine coccidioidomycosis.

Shubitz LF, Dial SM, Galgiani JN.

Vet Pathol. 2011 Sep;48(5):1008-11. doi: 10.1177/0300985810384410. Epub 2010 Oct 7.

PMID:
20930107
15.

Vaccine-induced cellular immune responses differ from innate responses in susceptible and resistant strains of mice infected with Coccidioides posadasii.

Shubitz LF, Dial SM, Perrill R, Casement R, Galgiani JN.

Infect Immun. 2008 Dec;76(12):5553-64. doi: 10.1128/IAI.00885-08. Epub 2008 Oct 13.

16.

Coccidioidomycosis in dogs and cats: a review.

Graupmann-Kuzma A, Valentine BA, Shubitz LF, Dial SM, Watrous B, Tornquist SJ.

J Am Anim Hosp Assoc. 2008 Sep-Oct;44(5):226-35. Review.

PMID:
18762558
17.

Comparative aspects of coccidioidomycosis in animals and humans.

Shubitz LF.

Ann N Y Acad Sci. 2007 Sep;1111:395-403. Epub 2007 Mar 1. Review.

PMID:
17332082
18.

Efficacy of ambruticin analogs in a murine model of coccidioidomycosis.

Shubitz LF, Galgiani JN, Tian ZQ, Zhong Z, Timmermans P, Katz L.

Antimicrob Agents Chemother. 2006 Oct;50(10):3467-9.

19.

Improved protection of mice against lethal respiratory infection with Coccidioides posadasii using two recombinant antigens expressed as a single protein.

Shubitz LF, Yu JJ, Hung CY, Kirkland TN, Peng T, Perrill R, Simons J, Xue J, Herr RA, Cole GT, Galgiani JN.

Vaccine. 2006 Jul 26;24(31-32):5904-11. Epub 2006 Apr 18.

PMID:
16759762
21.

Coccidioidomycosis: a diagnostic challenge.

Shubitz LF, Dial SM.

Clin Tech Small Anim Pract. 2005 Nov;20(4):220-6. Review.

PMID:
16317911
22.

Constrictive pericarditis secondary to Coccidioides immitis infection in a dog.

Shubitz LF, Matz ME, Noon TH, Reggiardo CC, Bradley GA.

J Am Vet Med Assoc. 2001 Feb 15;218(4):537-40, 526.

PMID:
11229504
23.

Resistance to Coccidioides immitis in mice after immunization with recombinant protein or a DNA vaccine of a proline-rich antigen.

Abuodeh RO, Shubitz LF, Siegel E, Snyder S, Peng T, Orsborn KI, Brummer E, Stevens DA, Galgiani JN.

Infect Immun. 1999 Jun;67(6):2935-40.

24.

Treatment of acute and chronic Cryptosporidium parvum infections in mice using clarithromycin and 14-OH clarithromycin.

Cama VA, Marshall MM, Shubitz LF, Ortega YR, Sterling CR.

J Eukaryot Microbiol. 1994 Sep-Oct;41(5):25S. No abstract available.

PMID:
7804227

Supplemental Content

Loading ...
Support Center